PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 70 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $886,000 | +38.7% | 22,599 | -16.5% | 0.29% | +146.2% |
Q2 2016 | $639,000 | +29.4% | 27,071 | +11.7% | 0.12% | +64.8% |
Q1 2016 | $494,000 | -65.1% | 24,237 | -51.5% | 0.07% | -47.4% |
Q4 2014 | $1,416,000 | +398.6% | 50,016 | +345.3% | 0.14% | +440.0% |
Q3 2014 | $284,000 | -87.4% | 11,232 | -85.4% | 0.02% | -85.9% |
Q2 2014 | $2,249,000 | +108.8% | 77,071 | +85.3% | 0.18% | +149.3% |
Q1 2014 | $1,077,000 | +21.3% | 41,586 | +20.6% | 0.07% | +69.0% |
Q4 2013 | $888,000 | +0.5% | 34,469 | +4.4% | 0.04% | +5.0% |
Q3 2013 | $884,000 | +296.4% | 33,029 | +263.5% | 0.04% | +344.4% |
Q2 2013 | $223,000 | – | 9,086 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |